European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.235-244, 2011. ,
DOI : 10.1016/j.ijpharm.2011.06.040
Committee for medicinal products for human use Guideline on pharmaceutical development of medicines for paediatric use, 2012. ,
A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms ??? An application for paediatric dosage form selection, International Journal of Pharmaceutics, vol.435, issue.2, pp.115-138, 2012. ,
DOI : 10.1016/j.ijpharm.2012.05.024
Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1760, 2013. ,
DOI : 10.1016/j.jpeds.2013.07.014
Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.725-756, 2013. ,
DOI : 10.1023/A:1012050931018
Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-243, 2009. ,
DOI : 10.1542/peds.2008-2059
A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms, The AAPS Journal, vol.15, issue.4, pp.1072-81, 2013. ,
DOI : 10.1208/s12248-013-9511-5
Solid oral dosage forms for children ? formulations, excipients and acceptance issues, Eur Industrial Pharm, vol.8, pp.4-7, 2011. ,
Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005. ,
DOI : 10.1016/j.ijpharm.2005.05.006
Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3, 2009. ,
DOI : 10.1016/j.ijpharm.2008.09.015
How Do You Improve Compliance?, PEDIATRICS, vol.115, issue.6, pp.718-742, 2005. ,
DOI : 10.1542/peds.2004-1133
Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates, Pediatric Critical Care Medicine, vol.10, issue.2, pp.256-265, 2009. ,
DOI : 10.1097/PCC.0b013e31819a383c
Safety issues with ethanol as an excipient in drugs intended for pediatric use, Expert Opinion on Drug Safety, vol.66, issue.4, pp.499-502, 2011. ,
DOI : 10.1097/SMJ.0b013e31819ba212
Reporting adverse drug reactions by proprietary name, The Lancet, vol.338, issue.8763, p.393, 1991. ,
DOI : 10.1016/0140-6736(91)90537-Y
European Study of Neonatal Exposure to Excipients: An update, International Journal of Pharmaceutics, vol.457, issue.1, pp.357-365, 2013. ,
DOI : 10.1016/j.ijpharm.2013.08.078
The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-112, 2012. ,
DOI : 10.1016/j.ijpharm.2012.05.004
The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-332, 2013. ,
DOI : 10.1016/j.ijpharm.2013.09.013
Adverse Drug Events in Pediatric Outpatients, Ambulatory Pediatrics, vol.7, issue.5, pp.383-392, 2007. ,
DOI : 10.1016/j.ambp.2007.05.005
Management of medication errors associated with the use of delivery devices for orally ingested liquid drugs Medication overdoses leading to emergency department visits among children, Am J Prev Med, vol.201337, pp.181-188, 2009. ,
Predictors of misunderstanding pediatric liquid medication instructions, Fam Med, vol.41, pp.715-736, 2009. ,
Parents' Medication Administration Errors, Archives of Pediatrics & Adolescent Medicine, vol.164, issue.2, pp.181-187, 2010. ,
DOI : 10.1001/archpediatrics.2009.269
URL : http://archpedi.jamanetwork.com/data/journals/peds/5184/poa90082_181_186.pdf
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001. ,
DOI : 10.1016/S0160-3450(15)31856-0
Polypharmacy: Its Cost Burden and Barrier to Medical Care in a Drug-Oriented Health Care System, International Journal of Health Services, vol.41, issue.2 ,
DOI : 10.1126/science.176.4034.488
Compliance With Prescription Filling in the Pediatric Emergency Department, Archives of Pediatrics & Adolescent Medicine, vol.154, issue.2, pp.195-203, 2000. ,
DOI : 10.1001/archpedi.154.2.195
Conditioning children when refusal of oral medication is life threatening, Pediatrics, vol.44, pp.969-72, 1969. ,
Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014. ,
DOI : 10.1016/0005-7916(80)90051-8
Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, pp.391-403, 2002. ,
DOI : 10.1007/BF02722324
When Do Children Convert from Liquid Antiretroviral to Solid Formulations?, Pharmacy World & Science, vol.12, issue.10, pp.399-402, 2005. ,
DOI : 10.2165/00128072-200204060-00002
A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984. ,
DOI : 10.1016/S0005-7894(84)80006-4
Teaching and maintaining pill-swallowing in HIV-infected children, AIDS Read, vol.10, pp.88-95, 2000. ,
Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005. ,
DOI : 10.1111/j.1365-2125.2005.02410.x
Committee for medicinal products for human use Guideline on pharmaceutical development of medicines for paediatric use, 2011. ,
L'administration des m??dicaments ?? l'enfant hospitalis??, Archives de P??diatrie, vol.11, issue.10, pp.1173-84, 2004. ,
DOI : 10.1016/j.arcped.2004.06.024
Pharmacokinetics of Lopinavir/Ritonavir Crushed Versus Whole Tablets in Children, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.58, issue.4, pp.385-91, 2011. ,
DOI : 10.1097/QAI.0b013e318232b057
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, p.81, 2013. ,
DOI : 10.1208/s12249-010-9515-8
The development of medicines for children, Pharmacological Research, vol.64, issue.3, pp.169-75, 2011. ,
DOI : 10.1016/j.phrs.2011.01.016
DRUG COMPLIANCE IN PEDIATRICS, Pediatric Clinics of North America, vol.44, issue.1, pp.1-14, 1997. ,
DOI : 10.1016/S0031-3955(05)70459-4
Primary non-compliance with prescribed medication in primary care., BMJ, vol.307, issue.6908, pp.846-854, 1993. ,
DOI : 10.1136/bmj.307.6908.846
Posologie des m??dicaments et observance, Archives de P??diatrie, vol.16, issue.6, pp.968-977, 2009. ,
DOI : 10.1016/S0929-693X(09)74221-6
Concordance and children's use of medicines, BMJ, vol.327, issue.7419, pp.858-60, 2003. ,
DOI : 10.1136/bmj.327.7419.858
Choisir la forme pharmaceutique orale la plus adapt??e ?? l???enfant, Archives de P??diatrie, vol.22, issue.8, pp.877-885, 2015. ,
DOI : 10.1016/j.arcped.2015.05.012
Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference, The Journal of Pediatrics, vol.120, issue.4, pp.634-642, 1992. ,
DOI : 10.1016/S0022-3476(05)82496-5
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial, The Journal of Pediatrics, vol.130, issue.2, pp.266-73, 1997. ,
DOI : 10.1016/S0022-3476(97)70353-6
Caretaker Compliance with Different Antibiotic Formulations for Treatment of Childhood Pneumonia, Journal of Tropical Pediatrics, vol.41, issue.2, pp.103-111, 1995. ,
DOI : 10.1093/tropej/41.2.103
Adherence issues in children and adolescents receiving highly active antiretroviral therapy, AIDS Care, vol.133, issue.3, pp.403-411, 2003. ,
DOI : 10.1080/09540129947613
Committee for Medicinal Products for Human Use (2013) Guideline on pharmaceutical development of medicines for paediatric use, 2012. ,
Human Medicines Development and Evaluation (2013) Examples of key binding elements in the PIP decisions, 2013. ,
Committee for Proprietary Medicinal Products Guideline on Pharmaceutical Development of Medicines for Paediatric Use, 2012. ,
L'administration des m??dicaments ?? l'enfant hospitalis??, Archives de P??diatrie, vol.11, issue.10, pp.1173-1184, 2004. ,
DOI : 10.1016/j.arcped.2004.06.024
Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1732, 1721. ,
DOI : 10.1016/j.jpeds.2013.07.014
Acceptability of Uncoated Mini-Tablets in Neonates???A Randomized Controlled Trial, The Journal of Pediatrics, vol.167, issue.4, pp.893-896, 2015. ,
DOI : 10.1016/j.jpeds.2015.07.010
Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014. ,
DOI : 10.1016/0005-7916(80)90051-8
Risk of medication error administering ciprofloxacin oral suspension in children, Eur. J. Clin. Pharmacol, issue.6, pp.71-769, 2015. ,
Oral drug dosage forms administered to hospitalized children: Analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period., International Journal of Pharmaceutics, vol.500, issue.1-2, pp.1-2, 2016. ,
DOI : 10.1016/j.ijpharm.2016.01.048
Crushed Tablets: Does the Administration of Food Vehicles and Thickened Fluids to Aid Medication Swallowing Alter Drug Release?, Journal of Pharmacy & Pharmaceutical Sciences, vol.17, issue.2, pp.207-219, 2014. ,
DOI : 10.18433/J39W3V
Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, pp.391-403, 2002. ,
DOI : 10.1007/BF02722324
Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-676, 2005. ,
DOI : 10.1111/j.1365-2125.2005.02410.x
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, 2013. ,
DOI : 10.1208/s12249-010-9515-8
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.1-2, 2011. ,
DOI : 10.1016/j.ijpharm.2011.06.040
The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-111, 2012. ,
DOI : 10.1016/j.ijpharm.2012.05.004
The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-322, 2013. ,
DOI : 10.1016/j.ijpharm.2013.09.013
Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study, Archives of Disease in Childhood, vol.97, issue.3, pp.283-286, 2012. ,
DOI : 10.1136/archdischild-2011-300958
Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005. ,
DOI : 10.1016/j.ijpharm.2005.05.006
Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.98-725, 2013. ,
DOI : 10.1023/A:1012050931018
The accuracy, precision and sustainability of different techniques for tablet subdivision: Breaking by hand and the use of tablet splitters or a kitchen knife, International Journal of Pharmaceutics, vol.466, issue.1-2, pp.1-2, 2014. ,
DOI : 10.1016/j.ijpharm.2014.02.031
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1-2, 2015. ,
DOI : 10.1016/j.ijpharm.2015.01.023
Factors influencing gender differences in the diagnosis and treatment of asthma in childhood: The Tucson Children's Respiratory Study, Pediatric Pulmonology, vol.172, issue.4, p.41, 2006. ,
DOI : 10.1164/ajrccm.158.2.9705079
CNRS Xavier Dode (Pharmacy Department, HCL) and the CNIHM (Drug Information National Hospital Centre, Thériaque 1 ) Alain Lachaux (Paediatric Hepatogastro-Enterology, Odile Boespflug-Tanguy (Paediatric Neurology and Metabolic DiseasesPaediatric Nephrology/Rheumatology, IBCP-UMR 5305CNRS, HCL/UCBL- Lyon1), Georges Deschênes (Paediatric Nephrology, CNRS- UMR7134, APHP), Vincent Des Portes (Paediatric Neurology HCL) Emilie Henin (CNRS UMR5558, UCBL-Lyon1), Evelyne Jacqz-Aigrain (Paediatric Pharmacology and Pharmacogenetics, Clinical Centre of Investigation, Inserm-U1426, APHP), Etienne Javouhey (Paediatric Intensive Care Unit Behrouz Kassai (Clinical Centre of Investigation, HCL) Salma Malik (Clinical Centre of Investigation, HCL), Catherine Michel (Computer and Information System Management, HCL), Yanis Minouni (Clinical Centre of Investigation, HCL) Marc Nicolino (Paediatric Endocrinology and Metabolic Diseases Nathalie Paret Benjamin Riche (CNRS UMR5558, HCL/UCBL-Lyon1), Aurélie Portefaix (Clinical Centre of Investigation, HCL), Corinne Pulce (Toxicovigilance and Poison Control Centre, HCL), Jean-Marc Sapori (Toxicovigilance and Poison Control Centre, HCL) Thierry Vial ,
Compliance with short-term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia, Journal of the Royal Society of Health, vol.43, issue.857, pp.231-234, 1995. ,
DOI : 10.1136/bmj.2.5857.18
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001. ,
DOI : 10.1016/S0160-3450(15)31856-0
Predictors of misunderstanding pediatric liquid medication instructions, Fam. Med, issue.10, pp.41-715, 2009. ,
European Paediatric Formulation Initiative (EuPFI), 2015. Formulating better medicines for children-reflections, Int. J. Pharm, pp.1-2 ,
Formulations for children: problems and solutions, British Journal of Clinical Pharmacology, vol.97, issue.S2, pp.405-418, 2015. ,
DOI : 10.1136/archdischild-2011-300909
URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12268/pdf
Changing physician behaviour, Archives of Disease in Childhood, vol.84, issue.6, pp.459-462, 2001. ,
DOI : 10.1136/adc.84.6.459
Factors influencing GPs??? choice between drugs in a therapeutic drug group. A qualitative study, Scandinavian Journal of Primary Health Care, vol.32, issue.4, pp.208-213, 2007. ,
DOI : 10.1093/019881092X.001.0001
Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3 ,
DOI : 10.1016/j.ijpharm.2008.09.015
Adherence to physicians' instructions as a factor in managing streptococcal pharyngitis, Pediatrics, vol.97, issue.6, pp.976-980, 1996. ,
Drug administration to paediatric inpatient, Arch. Pediatr, issue.10, pp.11-1173, 2004. ,
Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014. ,
DOI : 10.1016/0005-7916(80)90051-8
Risk of medication error administering ciprofloxacin oral suspension in children, Eur. J. Clin. Pharmacol, issue.6, pp.71-769, 2015. ,
A MiniReview of the Use of Hospital-based Databases in Observational Inpatient Studies of Drugs, Basic & Clinical Pharmacology & Toxicology, vol.25, issue.1, pp.13-18, 2013. ,
DOI : 10.1177/1062860609359934
The Relationship Between Perceived Parental Expectations and Pediatrician Antimicrobial Prescribing Behavior, Pediatrics, vol.103, issue.4, pp.711-718, 1999. ,
DOI : 10.1542/peds.103.4.711
Drug compliance in pediatrics. Clinical and research issues, Pediatr. Clin. N. Am, vol.4, issue.1, pp.1-14, 1997. ,
Inadequacies in the pharmacologic management of ambulatory children, The Journal of Pediatrics, vol.87, issue.1, pp.137-141, 1975. ,
DOI : 10.1016/S0022-3476(75)80090-4
Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-676, 2005. ,
DOI : 10.1111/j.1365-2125.2005.02410.x
Demonstrating Evidence of Acceptability: The ???Catch-22??? of Pediatric Formulation Development, Clinical Pharmacology & Therapeutics, vol.32, issue.5, pp.582-584, 2013. ,
DOI : 10.1016/j.clinthera.2010.05.005
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatrics, vol.14, issue.1, p.81, 2013. ,
DOI : 10.1208/s12249-010-9515-8
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.1-2, 2011. ,
DOI : 10.1016/j.ijpharm.2011.06.040
Factors that Influence Prescribing Decisions, Annals of Pharmacotherapy, vol.149, issue.4, pp.557-562, 2004. ,
DOI : 10.1001/archinte.163.18.2213
Orodispersible drug formulations for children and elderly, European Journal of Pharmaceutical Sciences, vol.75, pp.2-9, 2015. ,
DOI : 10.1016/j.ejps.2015.02.015
Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study, Archives of Disease in Childhood, vol.97, issue.3, pp.283-286, 2012. ,
DOI : 10.1136/archdischild-2011-300958
Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005. ,
DOI : 10.1016/j.ijpharm.2005.05.006
Rationale Antibiotikatherapie bei p??diatrischen Infektionen, Infection, vol.60, issue.S2, pp.74-78, 1995. ,
DOI : 10.11150/kansenshogakuzasshi1970.60.549
Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey, BMC Health Services Research, vol.31, issue.1, p.150, 2009. ,
DOI : 10.1111/j.1365-2710.2006.00776.x
Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-238, 2009. ,
DOI : 10.1542/peds.2008-2059
Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, pp.98-725, 2013. ,
DOI : 10.1023/A:1012050931018
Methods of administering oral formulations and child acceptability, International Journal of Pharmaceutics, vol.491, issue.1-2, pp.1-2, 2015. ,
DOI : 10.1016/j.ijpharm.2015.06.047
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1-2, 2015. ,
DOI : 10.1016/j.ijpharm.2015.01.023
Problems with oral formulations prescribed to children: a focus group study of healthcare professionals, International Journal of Clinical Pharmacy, vol.6, issue.3, pp.1057-1067, 2015. ,
DOI : 10.18433/J38887
Conference Report: Formulating Better Medicines for Children: 4th European Paediatric Formulation Initiative Conference, Therapeutic Delivery, vol.4, issue.1, pp.21-25, 2013. ,
DOI : 10.1016/j.ijpharm.2012.05.070
Parents' Medication Administration Errors, Archives of Pediatrics & Adolescent Medicine, vol.164, issue.2, pp.181-186, 2010. ,
DOI : 10.1001/archpediatrics.2009.269
New treatments of epilepsy in infancy] Archives de pediatrie, p.272 ,
Oral formulation of choice for children] Archives de 276 pediatrie : organe officiel de la Societe francaise de pediatrie, pp.877-85, 2015. ,
European Paediatric Formulation Initiative's 278 (EuPFI) 2nd conference commentary--Formulating better medicines for children. International journal 279 of pharmaceutics, pp.235-244, 2011. ,
Lack of pediatric drug formulations, Pediatrics, vol.104, pp.607-616, 1999. ,
Lack of appropriate formulations of medicines for children in the community, Acta Paediatrica, vol.104, issue.3, pp.1486-1495, 2003. ,
DOI : 10.1111/j.1651-2227.2003.tb00837.x
Drug compliance in pediatrics. Clinical and research issues. Pediatric clinics of 285 ,
Adherence to physicians' instructions as a factor in managing streptococcal 287 pharyngitis, Pediatrics, vol.97, pp.976-80, 1996. ,
Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy, JAMA, vol.305, issue.16, pp.1669-76, 2011. ,
DOI : 10.1001/jama.2011.506
The role of medication and sugars in pediatric dental patients, p.291 ,
Issues in the Formulation of Drugs for Oral Use in Children, Pediatric Drugs, vol.7, issue.3, pp.371-380, 2002. ,
DOI : 10.2165/00128072-200204060-00004
Inadequacies in the pharmacologic management of 295 ambulatory children. The Journal of pediatrics, pp.137-178, 1975. ,
Risk of medication error administering ciprofloxacin oral suspension in children, European Journal of Clinical Pharmacology, vol.71, issue.6, pp.769-70, 2015. ,
DOI : 10.1007/s00228-015-1842-y
Formulation of medicines for children British journal of clinical 299 pharmacology, pp.674-680, 2005. ,
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup, Tropical Medicine and International Health, vol.29, issue.7, pp.496-504, 2001. ,
DOI : 10.1016/S0160-3450(15)31856-0
When do children convert from liquid antiretroviral to solid 304 formulations? Pharm World Sci, pp.399-402, 2005. ,
Efficacy of a pill-swallowing training intervention to 306 ,
Acceptance of uncoated mini-tablets in young 309 children: results from a prospective exploratory cross-over study. Archives of disease in childhood, pp.310-283, 2012. ,
Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.235-243, 2009. ,
DOI : 10.1542/peds.2008-2059
Acceptability of different oral 314 formulations in infants and preschool children, Archives of disease in childhood, pp.315-336, 2013. ,
Teaching and maintaining pill- 316 swallowing in HIV-infected children, AIDS Reader, vol.10, issue.317, pp.88-95, 2000. ,
Pharmacological and Therapeutic Properties of Valproate, CNS Drugs, vol.20, issue.1, pp.695-714, 2002. ,
DOI : 10.3171/jns.1997.87.2.0252
Comparison of sprinkle versus syrup 325 formulations of valproate for bioavailability, tolerance, and preference. The Journal of pediatrics, pp.634-642, 1992. ,
Acceptability and tolerance 328 of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic 329 children from 3 years old] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie Committee for Medicinal Products for Human Use. Reflection 332 paper: formulations of choice for the paediatric population, pp.1533-1542, 2005. ,
European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline 340 on pharmaceutical development of medicines for paediatric use, 2011. ,
Effectiveness of Pediatric Pill Swallowing Interventions: A Systematic Review, PEDIATRICS, vol.135, issue.5, pp.883-892, 2015. ,
DOI : 10.1542/peds.2014-2114
Pill Swallowing Ability and Training in Children 6 to 11 Years of Age, Clinical Pediatrics, vol.94, issue.7, pp.725-758, 2006. ,
DOI : 10.1016/S0140-6736(97)07302-9
A behavioral treatment for difficulty in swallowing pills Journal of behavior 347 therapy and experimental psychiatry, pp.127-135, 1986. ,
A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984. ,
DOI : 10.1016/S0005-7894(84)80006-4
Operational classification of seizure types by the 351 ,
Medicines for children: a matter of taste. The Journal of pediatrics, pp.599-604, 2008. ,
Comparing compliance patterns between randomized treatments, Controlled Clinical Trials, vol.18, issue.3, p.356 ,
DOI : 10.1016/S0197-2456(96)00235-8
Safety of Chewable Tablets for Children, Journal of Asthma, vol.51, issue.5, p.358 ,
DOI : 10.1007/BF02722324
A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation, Clinical Pharmacokinetics, vol.47, issue.3, pp.305-322, 2015. ,
DOI : 10.1080/15563650902752376
Therapeutic follow-up observational study and population kinetics ancillary study 366 of valproate microgranules (Micropakine® SR) in patients aged between 6 months and 15 years 367 suffering from epilepsy, VAPOP Study, 2009. ,
A multivariable analysis of factors governing the steady, p.369 ,
Valproic acid pharmacokinetics in children, p.371 ,
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.783-90, 2004. ,
DOI : 10.1007/s00228-003-0699-7
Population pharmacokinetics of valproate in Chinese children with epilepsy, Acta Pharmacologica Sinica, vol.7, issue.10, pp.1677-84, 2007. ,
DOI : 10.1111/j.1365-2125.2004.02241.x
Valproate population pharmacokinetics in children, Journal of Clinical Pharmacy and Therapeutics, vol.27, issue.1, pp.73-80, 1999. ,
DOI : 10.1111/j.1365-2125.1989.tb05372.x
A Model for Estimating Individualized Valproate Clearance Values in Children, The Journal of Clinical Pharmacology, vol.65, issue.10, pp.1020-1024, 1995. ,
DOI : 10.1111/j.1600-0404.1982.tb03106.x
Factors influencing valproate pharmacokinetics in children and adults, Int. Journal of Clinical Pharmacology and Therapeutics, vol.48, issue.11, pp.767-75, 2010. ,
DOI : 10.5414/CPP48767
Pharmacokinetics of valproic acid after 384 administration of three oral formulations in healthy adults, J Assoc Physicians India, vol.38, pp.629-659, 1990. ,
Design evaluation and optimisation in multiple response 390 nonlinear mixed effect models: PFIM 3.0. Comput Methods Programs Biomed, pp.55-65, 2010. ,
Clinical pharmacokinetics of antiepileptic drugs in 392 paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide, p.393 ,
Favorable acceptance of mini-tablets compared 395 with syrup: a randomized controlled trial in infants and preschool children. The Journal of pediatrics, pp.1728-1760, 2013. ,
The evolution of antiepileptic drug 398 development and regulation. Epileptic disorders : international epilepsy journal with videotape, pp.3-399, 2010. ,
Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy, Epilepsy Research, vol.100, issue.1-2, pp.142-51, 2012. ,
DOI : 10.1016/j.eplepsyres.2012.02.005
Electronic measurement of medication 403 ,
Solid oral forms availability in children: a cost saving investigation, British Journal of Clinical Pharmacology, vol.11, issue.5, pp.1080-1089, 2014. ,
DOI : 10.1016/0005-7916(80)90051-8
Patient-Centred Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations, Drugs, vol.370, issue.106, pp.1871-89, 2014. ,
DOI : 10.1016/j.ijpharm.2008.11.005
Regulatory perspectives on acceptability testing of dosage forms in children, International Journal of Pharmaceutics, vol.469, issue.2, pp.245-253, 2014. ,
DOI : 10.1016/j.ijpharm.2014.03.057
Paediatric formulations???Getting to the heart of the problem, International Journal of Pharmaceutics, vol.300, issue.1-2, pp.56-66, 2005. ,
DOI : 10.1016/j.ijpharm.2005.05.006
Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3, 2009. ,
DOI : 10.1016/j.ijpharm.2008.09.015
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary???Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.235-244, 2011. ,
DOI : 10.1016/j.ijpharm.2011.06.040
10-year Report to the European Commission -General report on the experience acquired as a result of the application of the Paediatric Regulation, 2016. ,
Pill-swallowing Training : A Brief Pediatric Oncology Report, Anglais, vol.15, issue.7, p.49, 2008. ,
Medicines for Children: A Matter of Taste, The Journal of Pediatrics, vol.153, issue.5, pp.599-604, 2008. ,
DOI : 10.1016/j.jpeds.2008.06.030
The economics of pediatric formulation development for off-patent drugs, Clinical Therapeutics, vol.30, issue.11, pp.2133-2178, 2008. ,
DOI : 10.1016/j.clinthera.2008.11.019
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.55-62, 2015. ,
DOI : 10.1016/j.ijpharm.2015.01.023
Overview of patient compliance with medication dosing: a literature review, Clin Ther, vol.6, issue.5, pp.592-601, 1984. ,
The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1???A need assessment study, International Journal of Pharmaceutics, vol.435, issue.2, pp.101-112, 2012. ,
DOI : 10.1016/j.ijpharm.2012.05.004
The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 ??? The pilot version, International Journal of Pharmaceutics, vol.457, issue.1, pp.310-332, 2013. ,
DOI : 10.1016/j.ijpharm.2013.09.013
Pediatric Drug Labeling, JAMA, vol.290, issue.7, pp.905-916, 2003. ,
DOI : 10.1001/jama.290.7.905
URL : http://jama.jamanetwork.com/data/journals/jama/4892/joc30331.pdf
Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors, Psychotherapy and Psychosomatics, vol.72, issue.2, pp.71-80, 2003. ,
DOI : 10.1159/000068691
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data, The Lancet, vol.363, issue.9418, pp.1341-1346, 2004. ,
DOI : 10.1016/S0140-6736(04)16043-1
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric, Bibliographie, vol.172, p.180 ,
The problems in scaling adult drug doses to children, Archives of Disease in Childhood, vol.93, issue.3, pp.207-218, 2008. ,
DOI : 10.1136/adc.2006.114835
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children, Journal of Clinical Epidemiology, vol.68, issue.10, pp.1221-1252, 2015. ,
DOI : 10.1016/j.jclinepi.2015.06.021
Dosing in neonates: special considerations in physiology and trial design, Pediatric Research, vol.14, issue.1-1, pp.1-12, 2015. ,
DOI : 10.1016/j.jchromb.2010.10.009
5-year Report to the European Commission -General report on the experience acquired as a result of the application of the Paediatric Regulation, 2012. ,
[New treatments of epilepsy in infancy] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, pp.1041-1045, 2007. ,
Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005. ,
DOI : 10.1111/j.1365-2125.2005.02410.x
Committee for Medicinal Products for Human Use. Guideline on pharmaceutical development of medicines for paediatric use, 2013. ,
Favorable Acceptance of Mini-Tablets Compared with Syrup: A??Randomized Controlled Trial in Infants and Preschool Children, The Journal of Pediatrics, vol.163, issue.6, pp.1728-1760, 2013. ,
DOI : 10.1016/j.jpeds.2013.07.014
Acceptability of different oral formulations in infants and preschool children, Archives of Disease in Childhood, vol.5, issue.4 Pt 1, 2013. ,
DOI : 10.1023/A:1012050931018
Committee for Medicinal Products for Human Use. Draft: Guideline on pharmaceutical development of medicines for paediatric use, 2011. ,
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial, The Journal of Pediatrics, vol.130, issue.2, pp.266-73, 1997. ,
DOI : 10.1016/S0022-3476(97)70353-6
Formulations for children: problems and solutions, British Journal of Clinical Pharmacology, vol.97, issue.S2, pp.405-423, 2015. ,
DOI : 10.1136/archdischild-2011-300909
URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12268/pdf
Teaching and maintaining pillswallowing in HIV-infected children, AIDS Reader, vol.10, issue.2, pp.88-95, 2000. ,
Efficacy of a Pill-Swallowing Training Intervention to Improve Antiretroviral Medication Adherence in Pediatric Patients With HIV/AIDS, PEDIATRICS, vol.119, issue.4, pp.893-902, 2007. ,
DOI : 10.1542/peds.2006-1488
A brief, effective method for teaching children to swallow pills, Behavior Therapy, vol.15, issue.4, pp.381-388, 1984. ,
DOI : 10.1016/S0005-7894(84)80006-4
A behavioral treatment for difficulty in swallowing pills, Journal of Behavior Therapy and Experimental Psychiatry, vol.17, issue.2, pp.127-135, 1986. ,
DOI : 10.1016/0005-7916(86)90050-9
Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated, The Cochrane Collaboration, 2011. ,
Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy, JAMA, vol.305, issue.16, pp.1669-76, 2011. ,
DOI : 10.1001/jama.2011.506
Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study, Neurology, vol.71, issue.20, pp.1572-1580, 2008. ,
DOI : 10.1212/01.wnl.0000319693.10338.b9
Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study, Epilepsia, vol.12, issue.Suppl. 7, pp.501-510, 2009. ,
DOI : 10.1017/S1092852900008464
The evolution of antiepileptic drug development and regulation. Epileptic disorders : international epilepsy journal with videotape, pp.3-15, 2010. ,
Pharmacological and Therapeutic Properties of Valproate, CNS Drugs, vol.20, issue.1, pp.695-714, 2002. ,
DOI : 10.3171/jns.1997.87.2.0252
Valproate as a Mainstay of Therapy for Pediatric Epilepsy, Pediatric Drugs, vol.33, issue.1-2, pp.113-142, 2006. ,
DOI : 10.1212/01.WNL.0000123693.82339.FC
Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, pp.1533-1542, 2005. ,
Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population, International Journal of Pharmaceutics, vol.480, issue.1-2, pp.1873-3476 ,
DOI : 10.1016/j.ijpharm.2015.01.023
Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference, The Journal of Pediatrics, vol.120, issue.4, pp.634-642, 1992. ,
DOI : 10.1016/S0022-3476(05)82496-5
Abstract, Clinical Chemistry and Laboratory Medicine (CCLM), vol.62, issue.11, pp.1228-55, 2004. ,
DOI : 10.1111/j.1365-2125.1987.tb03247.x
Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-97, 2005. ,
DOI : 10.1056/NEJMra050100
Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric Patients, Clinical Pharmacokinetics, vol.29, issue.4, pp.257-86, 1995. ,
DOI : 10.2165/00003088-199529040-00005
A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation, Clinical Pharmacokinetics, vol.47, issue.3, pp.305-322, 2015. ,
DOI : 10.1080/15563650902752376
Therapeutic follow-up observational study and population kinetics ancillary study of valproate microgranules (Micropakine ® SR) in patients aged between 6 months and 15 years suffering from epilepsy. VAPOP Study, 2009. ,
A Multivariable Analysis of Factors Governing the Steady-State Pharmacokinetics of Valproic Acid in 52 Young Epileptics, The Journal of Clinical Pharmacology, vol.28, issue.4, pp.261-269, 1985. ,
DOI : 10.1038/clpt.1980.192
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients, European Journal of Clinical Pharmacology, vol.59, issue.11, pp.783-90, 2004. ,
DOI : 10.1007/s00228-003-0699-7
Population pharmacokinetics of valproate in Chinese children with epilepsy, Acta Pharmacologica Sinica, vol.7, issue.10, pp.1677-84, 2007. ,
DOI : 10.1111/j.1365-2125.2004.02241.x
A Model for Estimating Individualized Valproate Clearance Values in Children, The Journal of Clinical Pharmacology, vol.65, issue.10, pp.1020-1024, 1995. ,
DOI : 10.1111/j.1600-0404.1982.tb03106.x
Factors influencing valproate pharmacokinetics in children and adults, Int. Journal of Clinical Pharmacology and Therapeutics, vol.48, issue.11, pp.767-75, 2010. ,
DOI : 10.5414/CPP48767
International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population ,
What do the suffixes - XR, ER, Chrono, Chronosphere - really mean as it pertains to modified-release antiepileptic drugs?, Journal of Clinical Pharmacy and Therapeutics, vol.38, issue.Suppl. 7, pp.373-83, 2010. ,
DOI : 10.1212/WNL.38.8.1319
Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults, J Assoc Physicians India, vol.38, issue.9, pp.629-659, 1990. ,
Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States, Epilepsy Research, vol.73, issue.3, pp.275-83, 2007. ,
DOI : 10.1016/j.eplepsyres.2006.11.005
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations, Drug Des Devel Ther, vol.2, pp.139-183, 2009. ,
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/j.cmpb.2009.09.012
URL : https://hal.archives-ouvertes.fr/inserm-00431457
Reflection paper formulations of choice for the paediatric population, 2005. ,
French health insurance databases: What interest for medical research?, La Revue de M??decine Interne, vol.36, issue.6, pp.411-7180, 2015. ,
DOI : 10.1016/j.revmed.2014.11.009